Coartem (Artemether-Lumefantrine) in Africa: The beginning of the end?

被引：56

作者：

Hastings, IM ^{[1
]}

Ward, SA ^{[1
]}

机构：

[1] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2005年 / 192卷 / 07期

关键词：

D O I：

10.1086/432554

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1303 / 1304

页数：2

共 7 条

[1] Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial [J].

Dorsey, G ;

Njama, D ;

Kamya, MR ;

Cattamanchi, A ;

Kyabayinze, D ;

Staedke, SG ;

Gasasira, A ;

Rosenthal, PJ .

LANCET, 2002, 360 (9350) :2031-2038

[2] The origins of antimalarial drug resistance [J].

Hastings, IM .

TRENDS IN PARASITOLOGY, 2004, 20 (11) :512-518

[3] The evolution of drug-resistant malaria: the role of drug elimination half-life [J].

Hastings, IM ;

Watkins, WM ;

White, NJ .

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2002, 357 (1420) :505-519

[4]

HASTINGS IM, 2006, IN PRESS TRENDS PARA

[5] In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem) [J].

Sisowath, C ;

Strömberg, J ;

Mårtensson, A ;

Msellem, M ;

Obondo, C ;

Björkman, A ;

Gil, JP .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (06) :1014-1017

[6] The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa:: A model of the selection of resistance by antifolate drugs and their combinations [J].

Watkins, WM ;

Sibley, CH ;

Hastings, IM .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (02) :163-173

[7]

World Health Organization, 2001, Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation

← 1 →